Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | — | 1 | — | — | — | 1 |
Colonic neoplasms | D003110 | — | C18 | — | 1 | — | — | — | 1 |
Rectal neoplasms | D012004 | — | — | — | 1 | — | — | — | 1 |
Drug common name | VUDALIMAB |
INN | vudalimab |
Description | Vudalimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4594617 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 4I9I5X3Z6N (ChemIDplus, GSRS) |